Pharmaron Beijing Co., Ltd. (SHE: 300759)

Pharmaron Beijing Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	2,401	5,919	1,497	3,544	2,942	4,460
Short-Term Investments	57.06	179.36	613.24	1,080	-	-
Trading Asset Securities	361.09	621.98	745.36	1,555	910.01	183.45
Cash & Short-Term Investments	2,819	6,720	2,856	6,178	3,852	4,643
Cash Growth	-16.47%	135.30%	-53.77%	60.37%	-17.03%	1345.95%
Accounts Receivable	2,607	2,636	2,214	1,424	1,210	946.17
Other Receivables	111.11	80.98	71.16	92.43	33.38	45.36
Receivables	2,718	2,717	2,286	1,516	1,249	991.53
Inventory	1,188	1,013	1,041	680.04	281.62	157.4
Other Current Assets	346.36	423.68	352.82	269.05	157.76	152.22
Total Current Assets	7,071	10,874	6,536	8,644	5,540	5,944
Property, Plant & Equipment	10,173	10,062	8,464	5,811	3,799	2,882
Long-Term Investments	968	1,005	1,008	762.67	401.7	190.3
Goodwill	2,788	2,781	2,688	2,096	1,166	203.29
Other Intangible Assets	786.01	789.06	802.53	692.94	566.08	420.57
Long-Term Deferred Tax Assets	190.34	153.22	58.79	15.6	8.44	6.37
Long-Term Deferred Charges	705.14	520.47	496.38	171.6	234.27	204.84
Other Long-Term Assets	314.85	291.22	438.91	195.99	193.05	82.34
Total Assets	22,997	26,477	20,493	18,389	11,909	9,935
Accounts Payable	503.04	412.22	406.35	315.53	191.5	117.98
Accrued Expenses	706.93	805.65	784.92	626.21	472.44	289.91
Short-Term Debt	556.13	577.07	662.77	421.76	377.27	213.95
Current Portion of Long-Term Debt	295.91	150.34	74.94	60.54	8.88	65.54
Current Portion of Leases	153.49	185.32	164.03	95.29	83.92	85.31
Current Income Taxes Payable	178.22	184.55	145.87	81.34	27.62	28.65
Current Unearned Revenue	796.97	740.87	832.14	679.62	473.29	271.55
Other Current Liabilities	719.99	598.47	841.4	701.7	346.87	196.79
Total Current Liabilities	3,911	3,654	3,912	2,982	1,982	1,270
Long-Term Debt	4,337	8,200	4,454	4,423	394.81	542.03
Long-Term Leases	450.54	585.2	760.51	284.34	186.61	132.92
Long-Term Unearned Revenue	384.87	391.71	152.38	149.44	158.13	111.61
Long-Term Deferred Tax Liabilities	241.51	290.04	261.01	173.3	106.91	40.78
Other Long-Term Liabilities	-	117.58	112.09	81.56	146.81	-
Total Liabilities	9,325	13,239	9,653	8,094	2,975	2,097
Common Stock	1,787	1,787	1,191	794.18	794.39	794.39
Additional Paid-In Capital	5,170	5,222	5,254	6,008	6,028	5,965
Retained Earnings	6,577	5,818	4,574	3,554	2,131	1,078
Treasury Stock	-478.97	-463.45	-668.04	-301.83	-45.47	-72.78
Comprensive Income & Other	-42.34	193.72	197.26	74.15	-38.22	2.32
Total Common Equity	13,013	12,557	10,549	10,129	8,870	7,767
Minority Interest	658.78	681.25	291.25	166.07	63.42	70.95
Shareholders' Equity	13,672	13,238	10,840	10,295	8,934	7,838
Total Liabilities & Equity	22,997	26,477	20,493	18,389	11,909	9,935
Total Debt	5,793	9,698	6,117	5,285	1,051	1,040
Net Cash (Debt)	-2,974	-2,977	-3,260	893.04	2,801	3,604
Net Cash Growth	-	-	-	-68.12%	-22.27%	-
Net Cash Per Share	-1.67	-1.68	-1.84	0.49	1.57	2.42
Filing Date Shares Outstanding	1,778	1,787	1,787	1,787	1,787	1,787
Total Common Shares Outstanding	1,780	1,787	1,787	1,787	1,787	1,787
Working Capital	3,160	7,220	2,624	5,662	3,559	4,675
Book Value Per Share	7.31	7.03	5.90	5.67	4.96	4.35
Tangible Book Value	9,439	8,987	7,058	7,340	7,138	7,143
Tangible Book Value Per Share	5.30	5.03	3.95	4.11	3.99	4.00
Buildings	4,588	3,971	3,347	2,473	1,673	1,603
Machinery	5,809	5,149	4,265	2,919	2,194	1,764
Construction In Progress	2,001	2,633	1,671	1,374	820.58	217.27

Source: S&P Capital IQ. Standard template. Financial Sources.